Drugs / JE vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01150942 | Aug 2010 → Sep 2012 | Japanese encephalitis | Boryung Pharmaceutical Co., Ltd | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | JE vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01150942 ↗ |
| Known as | ENCEVAC | “inactivated Japanese encephalitis vaccine (KD-287, ENCEVAC®) versus a mouse brain-derived inactivated Japanese encephalitis vaccine in children” PMID 25567119 ↗ Jan 2015 |
| Modality | Vaccine | “Vero cell culture-derived, inactivated vaccine” PMID 25567119 ↗ Jan 2015 |
| Route | Intramuscular | “3 times, IM” NCT01150942 ↗ |